Drug Shortage Report for CIMETIDINE
Report ID | 243589 |
Drug Identification Number | 00487872 |
Brand name | CIMETIDINE |
Common or Proper name | CIMETIDINE |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CIMETIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 BTL |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-11-19 |
Actual start date | |
Estimated end date | 2024-12-06 |
Actual end date | 2024-12-03 |
Shortage status | Resolved |
Updated date | 2024-12-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-12-05 | French | Compare |
v3 | 2024-12-05 | English | Compare |
v2 | 2024-11-21 | French | Compare |
v1 | 2024-11-21 | English | Compare |
Showing 1 to 4 of 4